1. Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan. (February 2021) Authors: Maneikis, Kazimieras; Ringeleviciute, Ugne; Bacevicius, Justinas; Dieninyte-Misiune, Egle; Burokaite, Emilija; Kazbaraite, Gintare; Monika Janusaite, Marta; Dapkeviciute, Austeja; Zucenka, Andrius; Peceliunas, Valdas; Kryzauskaite, Lina; Kasiulevicius, Vytautas; Ringaitiene, Donata; Zablockiene, ... Journal: IJC heart & vasculature Issue: Volume 32(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Outcomes of relapsed or refractory acute myeloid leukemia patients failing venetoclax‐based salvage therapies. (27th October 2020) Authors: Zucenka, Andrius; Pileckyte, Regina; Trociukas, Igoris; Peceliunas, Valdas; Vaitekenaite, Vilmante; Maneikis, Kazimieras; Davainis, Linas; Zvirblis, Tadas; Stoskus, Mindaugas; Gineikiene, Egle; Norvilas, Rimvydas; Dirse, Vaidas; Surauciute, Agne; Zucenkiene, Emile; Griskevicius, Laimonas Journal: European journal of haematology Issue: Volume 106:Number 1(2021) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Venetoclax in combination with low dose Cytarabine and Actinomycin D for primary refractory acute myeloid leukemia patients failing intensive chemotherapy. (December 2021) Authors: Daraskevicius, Justinas; Everatt, Veronika; Vaitekenaite, Vilmante; Ringeleviciute, Ugne; Maneikis, Kazimieras; Zucenka, Andrius Journal: Leukemia research Issue: Volume 111(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗